Table 1.
Sociodemographic and Clinical Variables
| Variable (N=191) | Total N=191 |
|---|---|
|
| |
| Mean ± SD age (yrs) | 53.2 ± 15.1 |
|
| |
| Gender: female | 162 (85%) |
|
| |
| Ethnicitya | |
| Caucasian | 168 (88%) |
|
| |
| Marital Statusa | |
| Married | 97 (51%) |
|
| |
| Living Arrangements | |
| With family/friends | 141 (74%) |
|
| |
| Education: | |
| College graduate | 113 (59%) |
|
| |
| Employment Statusa | |
| Full-time | 36 (19%) |
| Part-time | 21 (11%) |
| Retired | 43 (23%) |
| Disabled | 77 (43%) |
|
| |
| PAH Etiology | |
| Idiopathic | 104 (55%) |
| Connective Tissue Disease | 34 (18%) |
| Congenital Heart Disease | 8 (4%) |
| Drugs (fenfluramine/phentermine) | 8 (4%) |
| NYHA Functional Class | |
| I | 22 (12%) |
| II | 36 (19%) |
| III | 54 (28%) |
| IV | 79 (41%) |
|
| |
| Oxygen Use | 115 (60%) |
|
| |
| Years since diagnosis | 6.3 ± 6.6 |
|
| |
| Medications | |
| Calcium Channel Blockers | 46 (24%) |
| Endothelin Receptor Antagonists | 95 (50%) |
| Phosphodiesterase Type-5 inhibitors (PDE-5) | 110 (58%) |
| Prostanoid analogues | 75 (39%) |
| Diuretics | 117 (61%) |
| Digoxin | 29 (15%) |
PAH = pulmonary arterial hypertension; NYHA = New York Heart Association.
a
P<0.05.